BGU

Maris-Tech Receives Grant Approval in the Amount of Approximately $156,000 from the Israel Innovation Authority for the Second Year of a Joint Development Project with the Ben Gurion University

Retrieved on: 
Friday, November 3, 2023
Ben-Gurion University of the Negev, Artificiality, BGU, Artificial intelligence, Partnership, Machine learning, AI, IIA, Israel Innovation Authority, Medical device

Rehovot, Israel, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of Artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced that it has a grant approval of approximately $156,000 from the Israel Innovation Authority (“IAA”) to support the second year of a joint development project with the Ben Gurion University of the Negev (“BGU”).

Key Points: 
  • The grant represents 66% of the total budget for the second year operation (or approximately $236,000) of the ongoing joint project to develop an advanced system based on AI and machine learning (“ML”) for diagnosing and predicting drone faults and malfunctions.
  • The total budget for the two-year project is approximately $695,000.
  • The aim of the project is to adapt and integrate an identification and prediction model developed at BGU in existing Maris-Tech systems.
  • The grant was approved based on the successful completion and meeting of the objectives of the first-year work plan and the continued successful collaboration between Maris-Tech and BGU.

Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology

Retrieved on: 
Tuesday, October 31, 2023
Knowledge, Gene editing, Litopenaeus, US, Disease resistance, Ben-Gurion University of the Negev, Economics, Seafood, CRISPR, RNA, BGU, Computational biology, Research, TASE, IIA, Generator, Israel Innovation Authority, CPO, Macrobrachium, Compound annual growth rate, Aquaculture, Appetite, Antibiotics

HAZEVA and REHOVOT, Israel, Oct. 31, 2023 /PRNewswire/ -- Colors Farm Ltd, a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. ("Evogene") (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product discovery and development, today announced a collaboration with Ben-Gurion University (BGU), a renowned Israeli academic research institution, to develop gene editing technology for crustaceans. This synergistic collaboration will focus on crustaceans — specifically targeting giant freshwater prawn (Macrobrachium rosenbergii), white leg shrimp (Litopenaeus vannamei) and red swamp crayfish (Procambarus clarkii), to enhance key traits such as growth rate, disease resistance, and environmental adaptation. The initiative has received a competitive grant from the Israel Innovation Authority (IIA), cementing its role as a pioneering endeavor in the realm of precision agriculture.

Key Points: 
  • Gene editing is a powerful tool that can enhance the economics and sustainability of crustacean production.
  • Ran Epstein, CEO of Colors Farm, emphasized the potential impact of gene editing on crustacean production: "This collaboration represents a major step forward for aquaculture.
  • Gene editing has the power to revolutionize crustacean production, and we are excited to work with Evogene and BGU to turn this potential into reality."
  • "We are pleased to collaborate with Colors Farm and BGU on this significant endeavor" said Nir Arbel, CPO of Evogene: "Through precise modifications of crustacean genomes, gene editing can enhance desired traits and minimize environmental impact.

Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks

Retrieved on: 
Tuesday, September 26, 2023
Benchmark, Data set, Sustainable Development Goal 9, Hallucination, United Nations, University, URL, Incubator, Synthetic media, Receiver, ML, Research, Sustainable Development Goals, Judgement, Ben-Gurion University of the Negev, Area, United, AI2, Generative, BGU, Curve, Observation, AI, API, Environment, Medical device, Phosphorus, Customer service, Mobile phone, Fujitsu

Professor Yuval Elovici, Ben Gurion University, comments: "Generative AI stands as a critical domain, and within it, the hallucination detection technology Fujitsu has developed emerges as pivotal for establishing trustworthy conversational AI systems.

Key Points: 
  • Professor Yuval Elovici, Ben Gurion University, comments: "Generative AI stands as a critical domain, and within it, the hallucination detection technology Fujitsu has developed emerges as pivotal for establishing trustworthy conversational AI systems.
  • Fujitsu will include these new technologies in its conversational AI core engine provided through the "Fujitsu Kozuchi (code name) - Fujitsu AI Platform," which offers users access to a wide range of powerful AI and ML technologies.
  • To address this issue, Fujitsu has developed a technology to detect manipulated URLs in the responses of conversational AI.
  • Fujitsu offers advanced technologies to corporate users via "Fujitsu Kozuchi (code name) - Fujitsu AI Platform" and to individual users through this portal site.

OncoHost Collaborates with BGN Technologies to Predict Cancer Patient Response to Anti-PD-1 Treatment with IcAR Biosensing Tech

Retrieved on: 
Thursday, May 4, 2023
Faculty, ICIS, Partnership, Drug development, ICI, Ligand, Cancer, Henney Kilowatt, Biomarker, Immunotherapy, Oncology, Patient, Physician, Medicine, PD-L2, BGU, Diagnosis, Ben-Gurion University of the Negev, PD-1, PD-L1, Palladium, Pharmaceutical industry, Medical imaging

BEER-SHEVA, Israel and BINYAMINA, Israel, May 4, 2023 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has signed an option agreement with BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), to receive a license for a novel biosensing technology called IcAR (Immuno-checkpoint Artificial Reporter). IcAR was developed by a team of researchers from BGU.

Key Points: 
  • With only 20-40% of cancer patients responding to immune checkpoint inhibitor (ICI) treatment, better biomarkers are desperately needed.
  • The IcAR biosensing technology measures the binding functionality of PD-1 ligands, PD-L1 and PD-L2, to their receptor, PD-1.
  • "IcAR technology is expected to be a game-changer in the world of cancer treatment diagnostics," said Prof. Elkabets.
  • In the future, this bioassay technology may help predict response to additional ICI therapies and could be used to tailor personalized treatment protocols.

Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)

Retrieved on: 
Tuesday, May 10, 2022
Transfer, Artery, Solution, Thrombectomy, Company, Stroke, Safety, Data, Leg, Patient, Pulmonary embolism, Thrombus, BGU, Aarhus University Hospital, FIH, Ben-Gurion University of the Negev, Breathe Me, BIOMED, PE, Prognosis, Efficiency, PERT, Embolism, Technology, CEO, Association of British HealthTech Industries, Medical imaging, Pharmaceutical industry, Computer data storage, Birth control, Magneto, Incentive

OR YEHUDA, Israel, May 10, 2022 /PRNewswire/ -- Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the treatment of ischemic stroke and pulmonary embolism, presented today successful first-in-human (FIH) results showing safety and feasibility of the eTrieve™ system, a novel catheter based on electric fields for removing blood clots, in patients with acute pulmonary embolism (PE). The data, presented today at Biomed Israel 2022, the premier international Life Science and HealthTech conference in Israel (May 10-12, Tel Aviv), showed a significant reduction in RV/LV ratio and alleviation of PE associated symptoms.

Key Points: 
  • "We are very pleased with our FIH results, which confirm the safety and efficiency of our innovative technology, as previously demonstrated in preclinical studies," said Benny Dilmoney, CEO of Magneto.
  • "Our novel catheter is a groundbreaking solution that can transform treatment of conditions caused by blood clots, such as pulmonary embolism.
  • PE is a rapidly growing market enhanced by the Pulmonary Embolism Response Team (PERT) approach for PE management.
  • Magneto Thrombectomy Solutions is developing innovative thrombectomy solutions for the treatment of ischemic strokes and pulmonary embolisms.

Madrigal Mental Care Develops Treatment for Post-Traumatic Stress Disorder Based on Psychedelic Drugs

Retrieved on: 
Monday, May 9, 2022
Transfer, People, Ben-Gurion University of the Negev, LSD, Psilocybin, Selective serotonin reuptake inhibitor, Tic disorder, Lysergic acid diethylamide, Department, Brain, Senior, Biochemistry, Student, Post-traumatic stress disorder, Lists of diseases, Company, Ketamine, Incubator, Nanoparticle, Depression, PayPal, Time, Cognition, Norepinephrine, Nanotechnology, Entrepreneurship, BGU, BGN, Diagnosis, Serotonin, Business development, Deutsche Telekom, Anxiety, Pharmacology, Patent, Serotonin–norepinephrine reuptake inhibitor, Wallace H. Coulter Department of Biomedical Engineering, MDMA, Trauma, Dell EMC, Mescaline, Psychotherapy, Government Hospital For Mental Care, PTSD, Technology, Research, Lockheed, Growth, Association of British HealthTech Industries, InterContinental, Online gambling, Pharmaceutical industry, BIOMED

BEER-SHEVA, Israel, May 9, 2022 /PRNewswire/ -- Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduces its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and HealthTech conference in Israel, on May 10-12, 2022, at the David InterContinental Hotel in Tel Aviv, Israel.

Key Points: 
  • "An increasing number of studies point to the advantages of using psychedelic drugs for the treatment of psychiatric disorders such as PTSD, depression, anxiety, obsessive compulsive disorder, and even addiction, with low doses," said Prof. Sintov.
  • The nanoparticles are biodegradable and provide a significant advantage over common practices in terms of stability and accuracy," stated David Gabay, Co-Founder, and Chairman of Madrigal Mental Care.
  • Based on Databridge, the psychedelic market is expected to reach 40$ billion by 2027 in the medical arena alone.
  • Madrigal Mental Care aims to redefine the future of mental health care by using cutting-edge, breakthrough nanotechnology to deliver psychedelic drugs.

BGN Technologies and Oazis Accelerator Establish DOTS, Developer of a Revolutionary Soil Nitrate Monitoring System for Agricultural Use

Retrieved on: 
Tuesday, December 14, 2021
Solution, Incubator, CEO, Deutsche Telekom, Ben-Gurion University of the Negev, BGU, PayPal, Technology, Soil, Efficiency, Drinking water, Department, Lockheed, General partnership, Lists of companies, Nitrate, Growth, Computer engineering, Agriculture, Nutrient, Reliance Industries, Groundwater, Forbes Global 2000, Dell EMC, DOTS, INR, Farmer, Marketing, Student, Research, Water, Program, Senior, University, LinkedIn, Water resources, Electricity, Fertilizer, Portrait, OurCrowd, Fortune Global 500, Multinational corporation, Entrepreneurship, The Zuckerberg Institute for Water Research, Doctor of Philosophy, Reliance, Industry, BGN, Fortune 500, Mentorship, Israel Innovation Authority

BEER-SHEVA, Israel, Dec. 14, 2021 /PRNewswire/ -- BGN Technologies , the technology transfer company of Ben-Gurion University of the Negev (BGU), announced the establishment of DOTS, developer of a new nitrate monitoring system for continuous real-time monitoring of nitrate levels in the soil for agricultural use.

Key Points: 
  • BEER-SHEVA, Israel, Dec. 14, 2021 /PRNewswire/ -- BGN Technologies , the technology transfer company of Ben-Gurion University of the Negev (BGU), announced the establishment of DOTS, developer of a new nitrate monitoring system for continuous real-time monitoring of nitrate levels in the soil for agricultural use.
  • Our new technology, which enables real-time monitoring of soil nitrate levels, can supply farmers with valuable data on nutrient availability for their crops.
  • Its ability to continuously monitor soil nitrate levels produces a highly detailed portrait of the rapidly changing concentrations of nitrate in the soil.
  • BGN Technologies brings technological innovations from the lab to the market and fosters research collaborations and entrepreneurship among researchersand students.

Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets

Retrieved on: 
Friday, November 19, 2021
Environment, Women, Men, Professional Services, Philanthropy, Fund Raising, Consumer, Foundation, Other Philanthropy, Other Professional Services, News, BGU, Business Wire, OCP Group, Public relations, Berkshire Hathaway, Twitter, Marketing, Organization, Blog, Public policy, ICL Group Ltd., LinkedIn, Multimedia

NEW YORK -- Church Pension Group to Host Conversation on the Investor Response to Climate Change Source: The Church Pension Group

Key Points: 
  • Public relations, investor relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
  • Business Wires global newsrooms are available to meet the needs of communications professionals and news media worldwide.
  • For more information about Business Wire, please email us at [email protected] or call 888.381.9473.
  • Subscribe to our blog for communications industry trends and tactics delivered straight to your inbox, and join us on Twitter @businesswire and LinkedIn .

Fujitsu and Ben-Gurion University Embark on Joint Research at New Center in Israel for Precise and Secure AI

Retrieved on: 
Tuesday, November 16, 2021
Learning, University, PayPal, Business, Industry, Science, BGU, Engineering, Behavior, Government, Student, Center, Dell EMC, Method, Heart, Incubator, CEO, Department, Information system, Humanities, Machine learning, Growth, Research, ICT, Software, AI, Head, Ben-Gurion University of the Negev, Entrepreneurship, Partnership, IL, Albert Katz International School for Desert Studies, Fraud, Lockheed, Solution, Faculty, Business process management, TÜBİTAK Informatics and Information Security Research Center, Deutsche Telekom, US, Social science, Outline of health sciences, Natural science, Bachelor of Engineering, Weapon, Medical device, Management

The newly-established "Fujitsu Cybersecurity Center of Excellence in Israel" (Fujitsu CCoE IL) hosts a team of approximately 20 researchers including Prof. Yuval Elovici and Prof. Asaf Shabtai.

Key Points: 
  • The newly-established "Fujitsu Cybersecurity Center of Excellence in Israel" (Fujitsu CCoE IL) hosts a team of approximately 20 researchers including Prof. Yuval Elovici and Prof. Asaf Shabtai.
  • Prof. Yuval Elovici, said, "We are excited to enhance our collaboration with Fujitsu, a world-leading information and communications technology company.
  • Together we can make systems that are based on AI more robust to attacks that focus on the AI component."
  • "This joint strategic research collaboration is a testament to Ben-Gurion University's leadership in the cybersecurity space," added Josh Peleg, CEO, BGN Technologies.

Fujitsu and Ben-Gurion University Embark on Joint Research at New Center in Israel for Precise and Secure AI

Retrieved on: 
Tuesday, November 16, 2021
University, BGU, Engineering, Behavior, Center, CEO, Department, Information system, Machine learning, Growth, Attack, Research, Software, AI, Head, Ben-Gurion University of the Negev, Partnership, Limited, IL, Solution, Cooperative Cyber Defence Centre of Excellence, TÜBİTAK Informatics and Information Security Research Center, Medical device

Vivek Mahajan,Chief Technology Officer of Fujitsu Limited commented, "We are delighted to collaborate with Ben-Gurion University, which boasts world-class software development capabilities in the security field.

Key Points: 
  • Vivek Mahajan,Chief Technology Officer of Fujitsu Limited commented, "We are delighted to collaborate with Ben-Gurion University, which boasts world-class software development capabilities in the security field.
  • Together we can make systems that are based on AI more robust to attacks that focus on the AI component."
  • "This joint strategic research collaboration is a testament to Ben-Gurion University's leadership in the cybersecurity space," added Josh Peleg, CEO, BGN Technologies.
  • As part of their new partnership, Fujitsu and BGU will focus on research that confronts these threats to make AI technologies safer and more trustworthy.